MedTrace Logo

Hepatocellular Carcinoma Surveillance in Cirrhotics

NCT04248816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 615

Last updated 2023-02-14

Study results available
· View outcomes & findings →

Summary

This is a 3-arm pilot randomized controlled trial applying behavioral economic approaches (opt-out framing and financial incentives) to encourage patients with liver cirrhosis to complete regular surveillance ultrasounds which may allow for earlier diagnosis of and better outcomes for hepatocellular carcinoma (HCC).

Conditions

Interventions

BEHAVIORAL

Usual care

Subjects will receive outreach through their providers as is standard of care.

BEHAVIORAL

Opt-out

Research staff will send a letter to patients encouraging them to get a surveillance ultrasound and include an order slip for them to get it done at a health system facility.

BEHAVIORAL

Opt-out + Incentive

Research staff will send a letter to patients encouraging them to get a surveillance ultrasound and include an order slip plus an unconditional $20 incentive for them to get it done at a health system facility.

Sponsors & Collaborators

Principal Investigators

  • Shivan Mehta, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-19
Primary Completion
2021-11-26
Completion
2022-02-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248816 on ClinicalTrials.gov